Viewing Study NCT00182390



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00182390
Status: COMPLETED
Last Update Posted: 2015-09-24
First Post: 2005-09-13

Brief Title: Premature Infants in Need of Transfusion PINT
Sponsor: McMaster University
Organization: McMaster University

Study Overview

Official Title: A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns 1000g Birth Weight
Status: COMPLETED
Status Verified Date: 2015-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hypothesis That a high hemoglobin threshold for transfusion in extremely low birth weight ELBW infants is associated with a lower rate of survival without severe morbidity defined as one or more of retinopathy of prematurity bronchopulmonary dysplasia or periventricular leukomalaciaventriculomegaly

Primary Objective To determine whether either a liberal or more restrictive threshold of hemoglobin level for red cell transfusion in ELBW infants is safer by randomizing to either a high transfusion hemoglobin threshold or a low transfusion hemoglobin threshold

Follow-up at a corrected age of 18 months represents a conventional age at which to first assess neurodevelopmental outcomes and to predict long-term outcomes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CIHR MCT-58455 None None None
CIHR MCT-41549 None None None